HIGHLIGHTS
- who: Geoff McCombe from the Estimation of HCV treatment monitoring costs HCV treatment costs (incurred in secondary care) were estimated based on information gathered through in-depth interviews carried out with the infectious disease clinical nurse specialist at Mater Misericordiae University Hospital where most patients diagnosed with HCV in the HepLink intervention were referred and treatedBased on these interviews and the detailed description of the treatment pathway, we mapped out all the activities, clinical assessments, laboratory investigations and follow up visits performed for an average patient. In short, all patients attending the infectious disease clinic with confirmed . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.